Grand Challenges Grant Opportunities and Updates

Dear Colleague,

We are excited to share the news about a new Grand Challenges initiative with open grant opportunities, grants recently awarded, last month’s annual Grand Challenges meeting, and the latest blog in the Innovation series.Grant opportunities: The Misk Foundation, the non-profit philanthropic foundation established by Saudi Arabia’s Crown Prince Mohammed bin Salman, and the Bill & Melinda Gates Foundation have partnered to launch Misk Grand Challenges. This initiative seeks to empower youth both with the skills that they need to succeed in the knowledge economy and with the passion required to tackle the world’s most challenging problems. Ultimately, the initiative hopes to nurture a new generation of leaders who will transform both local and global communities. Learn about the initiative and the associated grant opportunities here.

Grand Challenges Explorations (GCE) grants awarded: Please see the announcement with links to descriptions of the latest set of awards and to Steve Buchsbaum’s blog. These awards include a set under a challenge launched through collaboration between the U.S. Agency for International Development (USAID) and the Gates Foundation. This challenge – Health Systems Strengthening: Ensuring Effective Health Supply Chains – resulted in over 500 submissions, with 14 awards made by the Foundation and 3 potential award nominees for USAID.

The next application round of Grand Challenges Exploration is in March 2018.

Grand Challenges Annual Meeting: Grand Challenges partners hosted the 13th Grand Challenges Annual Meeting on October 2 – 4, this year in Washington, DC. You can watch videos of the plenary program focused on innovation to advance global health security, including:

Blog series on innovation: Trevor Mundel, the Gates Foundation’s President of Global Health, recently published two new blogs in his series on innovation: one on expanding the fight against malaria by focusing not only on Plasmodium falciparum but also on P. Vivax and a second blogexploring how innovation is accelerating progress on addressing neglected tropical diseases.

We congratulate the new GCE grantees and invite you to explore an interactive world map of funded ideas across the global Grand Challenges network committed to solving the world’s greatest health and development challenges.

The Grand Challenges Team
__________________________________

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives.

Visit our site
https://gcgh.grandchallenges.org/

Privacy Policy
http://www.gatesfoundation.org/privacy-policy

PO Box 23350

Seattle, WA. 98102

(C) 2014-2019 Bill & Melinda Gates Foundation.

All Rights Reserved.


Crain’s Michigan Business, spotlighting Michigan Tech, Innovation Shore

Crain’s Detroit Business has published a special edition of Crain’s Michigan Business, spotlighting Michigan Tech, Innovation Shore and several local businesses that spun off from Tech and the MTEC SmartZone. University Marketing & Communications helped the Crain’s reporter, Tom Henderson, put this package together.

http://www.crainsdetroit.com/article/20171112/news/644841/crains-michigan-business-high-tech-houghton-hancock


Advanced mass spectrometry course in Spring

Students & Faculty
I’m pleased to announce that we’ve just opened up an undergraduate level (CH4800; CRN 14633) advanced mass spectrometry course to be taught in parallel to the current graduate level (CH5240; CRN 14481).  Please note that this course is available only during the Spring semester of even years (e.g., Spring 2018, Spring 2020, etc.).
For graduate students, we also have a laboratory course (CH5241; CRN 14482) that provides hands-on experience.  The laboratory course is required for future “trusted users” of the MRI funded Orbitrap Elite MS in the Chemical Advanced Resolution Methods (ChARM) core facility.  Past students participated in a class research project to develop methods for dissolved organic phosphorus in wastewater effluent.  This year’s group will focus on the detailed molecular chemistry of Lake Effect snow.
Course Description:
The focus of this course is advanced mass spectrometry (MS) methods.  We will study a wide variety of mass analyzers including quadrupole, time of flight, ion trap, ion cyclotron resonance, and orbitrap.  Since MS analysis can only be performed on ionized molecules, a variety of analyte introduction techniques will also be studied.  Molecular identification methods including the use of tandem mass spectrometric analysis (aka MS/MS) and exact mass analysis will also be covered.  Students will then apply the fundamentals of these topics to identify unknown natural compounds from mass spectra and develop analytical strategies. 
Course Learning Objectives:
• Describe the theory of ionization and ion fragmentation.
• Compare and contrast the various ionization methods with respect to analyte structure and analytical application.
• Describe the strengths and weaknesses of several mass analyzers in terms of the elements of the instrument design and intended applications.
• Evaluate mass spectrometry data to elucidate molecular structures and/or qualitative empirical formulas and other metrics.
• Design and evaluate analytical methods, including tandem mass spectrometry methods, for various applications.
• Assimilate a literature review presentation of an advanced mass spectrometry method from the peer-reviewed literature.
Lynn R. Mazzoleni, Ph.D.

Associate Professor

Department of Chemistry and

Atmospheric Science Program
Michigan Technological University
1400 Townsend Drive
Houghton, MI 49931
Email: lrmazzol@mtu.edu
(+1) 906-487-1853

NAE Awards: Nominations open Jan 1, 2018

Nominations for the 2018 Simon Ramo Founders Award, the 2018 Arthur M. Bueche Award, the 2019 Fritz J. and Dolores H. Russ Prize, and the 2019 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education will be accepted beginning January 1, 2018.


Fundamentals of Engineering (FE) Exam

Dear Seniors,

As you look for employment, keep in mind that being on track to becoming a “Licensed Professional Engineer” will be a highly visible extra.  Licensing may be required for some jobs.  It is required in all states before you can enter private practice in engineering.

Graduating with an ABET-approved engineering degree and passing the Fundamentals of Engineering (FE) Exam are your first steps to becoming a Licensed Professional Engineer.  The FE Exam covers broad engineering fundamentals, and NOW is when you will be best prepared to pass it.

THE COMPUTER-BASED FE EXAM IS OFFERED AT MICHIGAN TECH, AND THE RESULTS ARE RECOGNIZED IN ALL STATES.

General information about the FE Exam, the testing location and time, and registration instructions can be found here: http://ncees.org/exams/fe-exam/
The $175 registration price (reduced from $225) will be available through NCEES starting January 1, 2018, so wait until after that date to register. 
Dr. Tony Rogers

Nominations open for 2018 MAGS Excellence in Teaching Awards

Nominations are now open for the Midwestern Association of Graduate Schools (MAGS) Excellence in Teaching Awards.  Michigan Tech may nominate one student at the MS and PhD level. Each graduate program may nominate one student at the MS and PhD level. Nominations are due to the Graduate School no later than 4pm, January 10, 2018.

Eligible students

  • will have been enrolled at Michigan Tech during the 2017 calendar year and have a teaching appointment
  • will have earned the Michigan Tech Outstanding Graduate Student Teaching Award
  • will have an excellent teaching portfolio and student evaluations

See the application page for complete details on what is required for a nomination.

Michigan Tech Graduate School
gradschool@mtu.edu

906-487-2327 (voice)

906-487-2284 (fax)

Resources for current students:
http://www.mtu.edu/gradschool/resources-for/students/

 


Deadline Approaching for Requesting IT Funded New Software

Michigan Tech IT provides funds for software above and beyond the funding available through your departmental budget. If you have a software need and want to apply for this funding, complete this form. The deadline is Wednesday (Nov. 15).

This application collects information about the source of funding, usage and the possible substitution or addition of software. All requests are then reviewed by the IT Software Group and the IT Governance Council. More information regarding the process can be found here.

Requests are prioritized and approved based on form responses and availability of funds. Not all requests may receive funding through this process.

There’s still time to submit your request. Here are two important dates to remember:

  • Nov. 15: The deadline for submitting a funding request for software

  • Jan. 15: The date you will receive a response to the software request based on budget availability, need and impact

If you have any questions on this process, or on any IT service, contact us at it-help@mtu.edu or call 7-1111.


NIH RFPs

Requests for Applications

  • Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
    (RFA-AG-18-021)
    National Institute on Aging
    Application Receipt Date(s): February 21, 2018, by 5:00 PM

  • Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01- Clinical Trial Optional)
    (RFA-DK-17-038)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 13, 2018, by 5:00 PM

  • Environmental Health Sciences Core Centers (EHS CC) (P30 Clinical Trial Optional)
    (RFA-ES-18-003)
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): April 17, 2018, April 17, 2019, by 5:00 PM

  • Contraception Research Centers Program (U54)
    (RFA-HD-18-035)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): January 9, 2018, by 5:00 PM

  • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) (Clinical Trial Required)
    (RFA-HL-18-027)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): February 20, 2018, by 5:00 PM

  • Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed)
    (RFA-MD-18-002)
    National Institute on Minority Health and Health Disparities
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): February 21, 2018, by 5:00 PM

  • BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
    (RFA-MH-18-510)
    Application Receipt Date(s): March 15, 2018; December 7, 2018; August 7, 2019; April 7, 2020, by 5:00 PM

  • NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed)
    (RFA-MH-18-600)
    Application Receipt Date(s): January 22, 2018, by 5:00 PM local time

  • Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not Allowed
    (RFA-MH-18-610)
    Application Receipt Date(s): January 8, 2018, by 5:00 PM

  • Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed)
    (RFA-MH-18-611)
    National Institute of Mental Health
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): January 8, 2018, by 5:00 PM

  • Translational Neural Devices (UG3/UH3 – Clinical Trial Required)
    (RFA-NS-18-011)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 21, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM

  • Translational Neural Devices (U44 – Clinical Trial Required)
    (RFA-NS-18-012)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 21, 2018; June 21, 2018; October 22, 2018; February 21, 2019; June 21, 2019; October 21, 2019; February 21, 2020; June 22, 2020; and October 21, 2020 , by 5:00 PM

Program Announcements

  • The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
    (PA-18-037)
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional)
    (PA-18-040)
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional)
    (PA-18-054)
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Multidisciplinary Research in Vulvodynia (R01 Clinical Trial Optional)
    (PA-18-089)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Office of Research on Women’s Health
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)
    (PA-18-096)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Office of Research on Women’s Health
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)
    (PA-18-137)
    National Institute of Nursing Research
    National Cancer Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Office of Research on Women’s Health
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Personalized Strategies to Manage Symptoms of Chronic Illness (R01 Clinical Trial Optional)
    (PA-18-138)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization

  • Innovative Questions in Symptom Science and Genomics (R01 Clinical Trial Optional)
    (PA-18-139)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization

  • Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01 Clinical Trial Optional)
    (PA-18-140)
    National Institute of Nursing Research
    National Center for Complementary and Integrative Health
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)
    (PA-18-141)
    Application Receipt/Submission Date(s): Standard dates, by 5:00 PM

  • Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01 Clinical Trial Optional)
    (PA-18-142)
    National Institute of Nursing Research
    National Institute of Environmental Health Sciences
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM

  • Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01 Clinical Trial Optional)
    (PA-18-143)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Health Promotion Among Racial and Ethnic Minority Males (R01 Clinical Trial Optional)
    (PA-18-144)
    National Institute of Nursing Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Use of Technology to Enhance Patient Outcomes and Prevent Illness (R01 Clinical Trial Optional)
    (PA-18-145)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01 Clinical Trial Optional)
    (PA-18-146)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R01 Clinical Trial Optional)
    (PA-18-147)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional)
    (PA-18-148)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional)
    (PA-18-149)
    National Institute of Nursing Research
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard AIDS dates apply by 5:00 PM

  • Promoting Caregiver Health Using Self-Management (R01 Clinical Trial Optional)
    (PA-18-150)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Chronic Condition Self-Management in Children and Adolescents (R01 Clinical Trial Optional)
    (PA-18-151)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Reducing Health Disparities Among Minority and Underserved Children (R01 Clinical Trial Optional)
    (PA-18-152)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
    (PA-18-155)
    National Institute of Nursing Research
    National Cancer Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Office of Research on Women’s Health
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Personalized Strategies to Manage Symptoms of Chronic Illness (R21 Clinical Trial Optional)
    (PA-18-156)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization

  • Innovative Questions in Symptom Science and Genomics (R21 Clinical Trial Optional)
    (PA-18-157)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization

  • Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional)
    (PA-18-158)
    National Institute of Nursing Research
    National Center for Complementary and Integrative Health
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)
    (PA-18-159)
    Application Receipt/Submission Date(s): Standard dates, by 5:00 PM

  • Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21 Clinical Trial Optional)
    (PA-18-160)
    National Institute of Nursing Research
    National Institute of Environmental Health Sciences
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM  The first standard application due date for this FOA is February 16, 2018.

  • Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)
    (PA-18-161)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Health Promotion Among Racial and Ethnic Minority Males (R21 Clinical Trial Optional)
    (PA-18-162)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21 Clinical Trial Optional)
    (PA-18-163)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21 Clinical Trial Optional)
    (PA-18-164)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R21 Clinical Trial Optional)
    (PA-18-165)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R21 Clinical Trial Optional)
    (PA-18-166)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional)
    (PA-18-167)
    National Institute of Nursing Research
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Chronic Condition Self-Management in Children and Adolescents (R21 Clinical Trial Optional)
    (PA-18-168)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional)
    (PA-18-169)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required)
    (PA-18-192)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional)
    (PA-18-193)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional)
    (PA-18-194)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required)
    (PA-18-197)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required)
    (PA-18-198)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional)
    (PA-18-199)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional)
    (PA-18-200)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional)
    (PA-18-201)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional)
    (PA-18-202)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional)
    (PA-18-210)
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • NIMH Exploratory/Developmental Research Grant (R21 – Clinical Trial Not Allowed)
    (PA-18-350)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Human Subjects Mechanistic and Minimal Risk Studies (R01 Clinical Trial Optional)
    (PA-18-351)
    National Eye Institute
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM

  • Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
    (PAR-18-008)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)
    (PAR-18-011)
    National Cancer Institute
    Application Receipt/Submission Date(s): February 14, 2018, June 28, 2018; October 11, 2018; February 14, 2019; June 28, 2019; October 11, 2019; February 14, 2020, by 5:00 PM

  • Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
    (PAR-18-019)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply), by 5:00 PM

  • Research on Informal and Formal Caregiving for Alzheimer’s Disease (R01 Clinical Trial Optional)
    (PAR-18-027)
    National Institute on Aging
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01 Clinical Trial Optional)
    (PAR-18-051)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
    (PAR-18-064)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): February 8, 2018; June 8, 2018; November 8, 2018, by 5:00 PM local time of applicant organization.

  • Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional)
    (PAR-18-091)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21 Clinical Trial Optional)
    (PAR-18-094)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03 Clinical Trial Optional)
    (PAR-18-095)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional)
    (PAR-18-126)
    National Heart, Lung, and Blood Institute
    Application Receipt/Submission Date(s): February 5, 2018; October 5, 2018; February 5, 2019; October 5, 2019 by 5:00 PM

  • Selected Topics in Transfusion Medicine (R21 Clinical Trial Optional)
    (PAR-18-132)
    National Heart, Lung, and Blood Institute
    Application Receipt/Submission Date(s): February 16, 2018; October 16, 2018; February 16, 2019; October 16, 2019, by 5:00 PM

  • Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional)
    (PAR-18-174)
    National Institute on Aging
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Research on Informal and Formal Caregiving for Alzheimer’s Disease (R21 Clinical Trial Optional)
    (PAR-18-179)
    National Institute on Aging
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Multiple dates, see announcement.

  • Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
    (PAR-18-206)
    Application Receipt/Submission Date(s): Standard dates, by 5:00 PM

  • Bioengineering Research Partnerships (U01 Clinical Trial Optional)
    (PAR-18-208)
    Application Receipt/Submission Date(s): May 8, 2018, September 13, 2018, by 5:00 PM local time of applicant organization.

  • Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Required)
    (PAR-18-261)
    National Institute of Environmental Health Sciences
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM

  • Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Not Allowed)
    (PAR-18-291)
    National Institute of Environmental Health Sciences
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM

  • Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 – No Independent Clinical Trials)
    (PAR-18-349)
    Application Receipt/Submission Date(s): March 6, 2018, and March 6, 2019, by 5:00 PM 

2018 Los Alamos Dynamics Summer School: Apply by Jan 7

Dear Alumni, Faculty and Staff,

Next summer, Los Alamos National Laboratory will be hosting the nineteenth edition of the Los Alamos Dynamics Summer School (LADSS). I have attached a flyer in PDF format that provides information about the summer school, links to more information on the web, and provides instructions for applying to the summer school.

Now that our curriculum and student projects are more in line with the National Science Foundation’s research thrust in cyber-physical systems, we are seeking participation by electrical engineers and computer scientists in addition to our traditional participation by aerospace, mechanical, and civil engineers. Therefore, please pass this solicitation on to prospective students and encourage the good ones to apply.  Applications will be accepted until January 7, 2018.

The primary goal of the LADSS is to get U.S. citizens to attend graduate school. Therefore, the students you solicit need to be U.S. citizens, and they should be of sufficient academic standing to be credible candidates for graduate school. As a reference point, the 200+ students that have taken part in the first eighteen LADSS schools had undergraduate GPA’s ranging from 3.0 – 4.0, with a mean undergraduate GPA of approximately 3.8.

Past experience shows that the students who actually apply to the Summer School are ones that faculty members or former students have talked to individually regarding this program, so please take the time to talk with some of your top students about this opportunity.

Also, please pass this solicitation on to other faculty that may have students who are interested in this educational/work opportunity. If you have any questions about the summer school, please contact me and I will be happy to answer them. Thanks for your help recruiting students for the Los Alamos Dynamics Summer School. Additional information may be found on our website at http://ladss.lanl.gov.

Thanks,

Chuck Farrar, Ph.D.

Engineering Institute

Los Alamos National Laboratory

LADSS Flyer 2018


Call for Abstracts Electronics & Microsystems

Call for Abstracts
Electronics & Microsystems at the
2018 TechConnect World Innovation Conference
in Anaheim, California


Early Submission Deadline – December 8th
(with 10% discount on registration):


The TechConnect World Innovation Conference is an annual event uniquely designed to accelerate the commercialization of innovations out of the lab and into industry. The Technical Program spotlights applications focused innovations, materials and devices emerging from industrial, government and academic laboratories worldwide. Please consider submitting an abstract and sharing your contribution to what’s new and what’s next in electronics & microsystems with our community of researchers and innovators, funding agency representatives, investment and corporate partners.

Symposia in the electronics and microsystems area include:

Other Industry Sectors include:

  • Advanced Materials
  • Advanced Manufacturing
  • Energy and Sustainability
  • Biotech and Medical
  • Personal & Home Care, Cosmetics, Food, Agriculture
We look forward to seeing you in Anaheim, California next May 13-16.